Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 12;7(3):42.
doi: 10.3390/ijns7030042.

Neonatal Screening for SCID: The French Experience

Marie Audrain  1 , Caroline Thomas  2
Affiliations
Review

Neonatal Screening for SCID: The French Experience

Marie Audrain et al. Int J Neonatal Screen. .

Abstract

After it was demonstrated in 2005 that T cell receptor excision circle (TREC) quantification for dried blood spot (DBS) samples on Guthrie cards is an effective means of SCID screening and following several pilot studies, the practice was formally recommended in the US in 2010. More and more countries have adopted it since then. In France, before the health authorities could recommend adding SCID to the list of five diseases that were routinely screened for, feasibility and cost-effectiveness studies had to be conducted with a sufficiently large cohort of neonates. We carried out three such studies: The first sought to verify the effectiveness of the assay. The second, DEPISTREC, evaluated the feasibility of universal SCID screening in France and assessed the clinical benefit and economic advantage it would provide. Through the third study, NeoSKID, still under way and to continue until recommendations are issued, we have been offering SCID screening in the Pays de la Loire region of France. This review briefly describes routine newborn screening (NBS) and management of primary immunodeficiency diseases (PIDs) in France, and then considers the lessons from our studies and the status of SCID screening implementation within the country.

Keywords: SCID; TREC quantification; neonatal screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The French NBS program.
Figure 2
Figure 2
Decision-making algorithm. BTA = beta-actin count (copies/µL); DBS = dried blood spot; T = term; pT = preterm; TC = TREC count (copies/µL).
Figure 3
Figure 3
Description of 62 cases of lymphopenia.
See this image and copyright information in PMC

References

    1. Chan K., Puck J.M. Development of Population-Based Newborn Screening for Severe Combined Immunodeficiency. J. Allergy Clin. Immunol. 2005;115:391–398. doi: 10.1016/j.jaci.2004.10.012. - DOI - PubMed
    1. Routes J.M., Grossman W.J., Verbsky J., Laessig R.H., Hoffman G.L., Brokopp C.D., Baker M.W. Statewide Newborn Screening for Severe T-Cell Lymphopenia. JAMA. 2009;302:2465–2470. doi: 10.1001/jama.2009.1806. - DOI - PubMed
    1. Comeau A.M., Hale J.E., Pai S.-Y., Bonilla F.A., Notarangelo L.D., Pasternack M.S., Meissner H.C., Cooper E.R., DeMaria A., Sahai I., et al. Guidelines for Implementation of Population-Based Newborn Screening for Severe Combined Immunodeficiency. J. Inherit. Metab. Dis. 2010;33:S273–S281. doi: 10.1007/s10545-010-9103-9. - DOI - PubMed
    1. Advisory Committee on Heritable Disorders in Newborns and Children, Summary of 20th Meeting, Washington, DC, USA, 21–22 January 2010. [(accessed on 24 May 2021)]; Available online: https://www.hrsa.gov/sites/default/files/hrsa/advisory-committees/herita....
    1. PID Life Index: Map. [(accessed on 28 June 2021)]; Available online: https://pidlifeindex.ipopi.org/#/en/principles/world-map.